Role of microRNA-709 in murine liver
dc.contributor.advisor | Morral, Nuria | |
dc.contributor.author | Surendran, Sneha | |
dc.contributor.other | Herbert, Brittney-Shea | |
dc.contributor.other | Ivan, Mircea | |
dc.contributor.other | Considine, Robert V. | |
dc.contributor.other | Carlesso, Nadia | |
dc.date.accessioned | 2015-04-10T13:45:00Z | |
dc.date.available | 2015-04-10T13:45:00Z | |
dc.date.issued | 2014 | |
dc.degree.date | 2014 | en_US |
dc.degree.discipline | Department of Medical & Molecular Genetics | en |
dc.degree.grantor | Indiana University | en_US |
dc.degree.level | Ph.D. | en_US |
dc.description | Indiana University-Purdue University Indianapolis (IUPUI) | en_US |
dc.description.abstract | MicroRNAs are small RNA molecules that regulate expression of genes involved in development, cell differentiation, proliferation and death. It has been estimated that in eukaryotes, approximately 0.5 to 1% of predicted genes encode a microRNA, which in humans, regulate at least 30% of genes at an average of 200 genes per miRNA. Some microRNAs are tissue-specific, while others are ubiquitously expressed. In liver, a few microRNAs have been identified that regulate specialized functions. The best known is miR-122, the most abundant liver-specific miRNA, which regulates cholesterol biosynthesis and other genes of fatty acid metabolism; it also regulates the cell cycle through inhibition of cyclin G1. To discover other miRNAs with relevant function in liver, we characterized miRNA profiles in normal tissue and identified miR-709. Our data indicates this is a highly abundant hepatic miRNA and is dysregulated in an animal model of type 2 diabetes. To understand its biological role, miR-709 gene targets were identified by analyzing the transcriptome of primary hepatocytes transfected with a miR-709 mimic. The genes identified fell within four main categories: cytoskeleton binding, extracellular matrix attachment, endosomal recycling and fatty acid metabolism. Thus, similar to miR-122, miR-709 downregulates genes from multiple pathways. This would be predicted, given the abundance of the miRNA and the fact that the estimated number of genes targeted by a miRNA is in the hundreds. In the case of miR-709, these suggested a coordinated response during cell proliferation, when cytoskeleton remodeling requires substantial changes in gene expression. Consistently, miR-709 was found significantly upregulated in an animal model of hepatocellular carcinoma. Likewise, in a mouse model of liver regeneration, mature miR-709 was increased. To study the consequences of depleting miR-709 in quiescent and proliferating cells, primary hepatocytes and hepatoma cells were cultured with antagomiRs (anti-miRs). The presence of anti-miR-709 caused cell death in proliferating cells. Quiescent primary hepatocytes responded by upregulating miR-709 and its host gene, Rfx1. These studies show that miR-709 targets genes relevant to cystokeleton structural genes. Thus, miR-709 and Rfx1 may be needed to facilitate cytoskeleton reorganization, a process that occurs after liver injury and repopulation, or during tumorigenesis. | en_US |
dc.identifier.uri | https://hdl.handle.net/1805/6164 | |
dc.identifier.uri | http://dx.doi.org/10.7912/C2/1957 | |
dc.language.iso | en_US | en_US |
dc.subject | microRNA, liver, hepatocellular carcinoma | en_US |
dc.subject.lcsh | Small interfering RNA -- Research -- Analysis -- Evaluation | en_US |
dc.subject.lcsh | Liver -- Cancer -- Research -- Methodology | en_US |
dc.subject.lcsh | Liver -- Regeneration | en_US |
dc.subject.lcsh | Gene expression -- Research | en_US |
dc.subject.lcsh | Liver -- Cancer -- Animal models | en_US |
dc.subject.lcsh | Hepatocyte growth factor -- Receptors | en_US |
dc.subject.lcsh | Mice as laboratory animals -- Research | en_US |
dc.title | Role of microRNA-709 in murine liver | en_US |
dc.type | Thesis | en |